Advertisement

Topics

ICON Reports Fourth Quarter and Full Year 2017 Results

06:00 EST 15 Feb 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Highlights Quarter 4 gross business wins of $718 million, a gross book to bill of 1.58. Net business wins of $599 million, a net book to bill of 1.32. Full year gross business wins of $2.6 billion, a gross ...

Other Sources for this Article

ICON plc
Investor Relations, 1-888-381-7923
or
Brendan Brennan, + 353 1 291 2000
Chief Financial Officer
or
Jonathan Curtain, +1 215 616 3000
Vice President Corporate Finance & Investor Relations
http://www.iconplc.com

NEXT ARTICLE

More From BioPortfolio on "ICON Reports Fourth Quarter and Full Year 2017 Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...